SCHEMBL31246119

SCHEMBL31246119

O=C(O)c1[nH]nnc1-c1ccc(-c2cccc(-c3ccccc3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMO O15229 2/20 0.46
ACMSD Q8TDX5 3/20 0.45
DHODH Q02127 1/20 0.43
HAO1 Q9UJM8 2/20 0.42
TP53 P04637 1/20 0.41
GP6 Q9HCN6 1/20 0.41
MAP2K4 P45985 2/20 0.41
MAPK1 P28482 1/20 0.41
MAPKAPK3 Q16644 1/20 0.41
MAPK6 Q16659 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
HNF4A P41235 2/20 0.40
DHFR P00374 1/20 0.40
MCL1 Q07820 1/20 0.40
HAO2 Q9NYQ3 1/20 0.40
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23303650 1.00 KMO (0.46) KMOACMSDDHODHHAO1TP53
SCHEMBL23294435 0.95 KMO (0.47) KMOACMSDDHODHHAO1TP53
SCHEMBL29851959 0.95 KMO (0.47) KMOACMSDDHODHHAO1TP53
SCHEMBL23294375 0.94 MAP2K4 (0.45) DHODHHAO1TP53MAP2K4MAPK1
SCHEMBL23294477 0.94 MAP2K4 (0.45) DHODHHAO1TP53MAP2K4MAPK1
SCHEMBL15946998 0.90 KDM4E (0.46) HAO1TP53MAP2K4MAPK1MAPKAPK3
SCHEMBL23294464 0.90 KMO (0.54) KMODHODHMAP2K4MAPK1MAPKAPK3
Hydrochloric Acid SCHEMBL3527570 0.89 KDM4E (0.44) HAO1TP53MAP2K4MAPK1MAPKAPK3
SCHEMBL23328966 0.88 MAP2K4 (0.41) HAO1MAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL23294377 0.88 HAO1 (0.46) KMOHAO1MAP2K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4051667-B1 HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS LILAC THERAPEUTICS INC (US) 2026-01-28 EP disclosed
CN-114929676-B Heterocyclic carboxylate compounds as glycolate oxidase inhibitors 紫丁香疗法有限公司 2025-04-29 CN disclosed
EP-4470538-A2 HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS Lilac Therapeutics, Inc. (US) 2024-12-04 EP disclosed